Table 1. Posterior probabilities obtained from the comparison between CD patients and controls stratified according a childhood- or adult-onset and between children and adults with CD.
| Gene | CD vs. Controls | CD children vs. CD adults | |
|---|---|---|---|
| Children | Adults | ||
| C1orf106 | 0.57 | 0.51 | 0.52 |
| C2orf74 | 0.58 | 0.73 | - |
| CCR4 | 0.58 | 0.79 | 0.72 |
| CCR6 | 0.68 | 0.62 | - |
| CD28 | - | 0.55 | - |
| FASLG | 0.72 | 0.63 | - |
| ICOSLG | 0.59 | - | 0.57 |
| IL18RAP | 0.54 | 0.60 | 0.51 |
| IL1RL1 (Hs01073297_m1) | - | 0.72 | 0.70 |
| IL23A | 0.70 | 0.69 | - |
| IL6 | 0.50 | 0.63 | 0.91 |
| JAK2 | 0.65 | 0.65 | - |
| PLEK | 0.52 | 0.61 | 0.51 |
| STAT3 | - | 0.56 | - |
| TAGAP | 0.56 | 0.52 | - |
| TMEM187 | - | 0.62 | - |
| TNFSF18 | 0.73 | - | 0.54 |
| UBE2L3 | 0.52 | 0.77 | - |
| VAMP3 | - | 0.55 | - |
| ZFP36L1 | - | 0.57 | - |